Prognostic Value of Hemoglobin, Albumin, Lymphocyte, and Platelet Score in Locally Advanced Nasopharyngeal Carcinoma
JunMei Song, Lan Luo, Ting Liu, YuQing Lv, Qiulin Huang, Rensheng Wang, Jun Bie · 2026
Read Prognostic Value of Hemoglobin, Albumin, Lymphocyte, and Platelet Score in Locally Advanced Nasopharyngeal Carcinoma by JunMei Song, Lan Luo, Ting Liu, YuQing Lv, Qiulin Huang, Rensheng Wang, Jun Bie (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13538944.txt.
Description
JunMei Song and co-authors tested a blood-based score for predicting survival in advanced throat-area cancer in a 2026 study. Nasopharyngeal carcinoma is treated with combined chemotherapy and radiation when locally advanced. The HALP score mixes hemoglobin, albumin, lymphocyte, and platelet levels into one number reflecting nutrition and immunity.
The team reviewed 295 patients treated between 2021 and 2022. Blood values from the week before treatment fed the score, and patients split into high and low groups at the median. Survival curves and regression models then compared outcomes, including spread to distant sites. A cheap score from routine labs could help doctors counsel patients more precisely.
Catalog record
| CREATOR | JunMei Song, Lan Luo, Ting Liu, YuQing Lv, Qiulin Huang, Rensheng Wang, Jun Bie |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |